Canada markets close in 5 hours 50 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.10500.0000 (0.00%)
As of 01:45PM EST. Market open.
Full screen
Previous Close0.1050
Open0.1050
Bid0.0950 x 0
Ask0.1050 x 0
Day's Range0.1050 - 0.1050
52 Week Range0.0500 - 0.1400
Volume1,000
Avg. Volume61,949
Market Cap13.844M
Beta (5Y Monthly)0.55
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateApr 18, 2024 - Apr 22, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair

    WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the special meeting of the shareholders of the Company held on February 20, 2024, Dr. Robert Huizinga was elected as a director of the Company. Mr. Huizinga has also been appointed by the directors of the Company as Executive Chair of the Company. In this new role in collaboration with Marc Edwards, President and Chief Executive Officer, Dr

  • GlobeNewswire

    Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray

    Kane will introduce its unique spray gel at the Boswick Burn and Wound Care SymposiumWINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel, and will be introducing it today at the Boswick Burn and Wound Care Symposium. “Kane has taken their revyve™ Anti

  • GlobeNewswire

    Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium

    WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be presenting its revyve™ Antimicrobial Wound Gel at the Boswick Burn and Wound Care Symposium. The international conference will take place from January 27 to February 1, 2024 in Maui, Hawaii and covers the latest advancements in wound healing, burn care, and infection control. During this conference, Kane Biotech will